Therapeutic Effects of Dual Dopaminergic Modulation With l-DOPA and Chlorpromazine in Patients With Idiopathic Cervical Dystonia.
Shinichi S MatsumotoHidetaka KoizumiHideki ShimazuSatoshi GotoPublished in: Neurology. Clinical practice (2024)
This study provides Class III evidence that treatment of botulinum toxin-resistant idiopathic cervical dystonia with l-DOPA and chlorpromazine is superior to either one alone.